about
Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's diseaseFunctional variant in a bitter-taste receptor (hTAS2R16) influences risk of alcohol dependence.Variants located upstream of CHRNB4 on chromosome 15q25.1 are associated with age at onset of daily smoking and habitual smokingA meta-analysis of two genome-wide association studies to identify novel loci for maximum number of alcoholic drinksGenome-wide survival analysis of age at onset of alcohol dependence in extended high-risk COGA familiesThe CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans.MAOA-uVNTR and early physical discipline interact to influence delinquent behavior.Cis-regulatory variants affect CHRNA5 mRNA expression in populations of African and European ancestry.Differential susceptibility to adolescent externalizing trajectories: examining the interplay between CHRM2 and peer group antisocial behavior.CHRM2, parental monitoring, and adolescent externalizing behavior: evidence for gene-environment interaction.Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.Variants in nicotinic receptors and risk for nicotine dependence.A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence.Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5.A Systematic single nucleotide polymorphism screen to fine-map alcohol dependence genes on chromosome 7 identifies association with a novel susceptibility gene ACN9Role of GABRA2 in trajectories of externalizing behavior across development and evidence of moderation by parental monitoring.Rare missense variants in CHRNB3 and CHRNA3 are associated with risk of alcohol and cocaine dependenceGenome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.CYP2A6 metabolism in the development of smoking behaviors in young adults.Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome.SORL1 variants across Alzheimer's disease European American cohorts.Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.Using dimensional models of externalizing psychopathology to aid in gene identification.Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1.Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSPAn atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associationsThe MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease riskThe TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion
P50
Q24312938-E0416F40-E2A1-48DB-B53A-B9FA29E36112Q24540485-401B3614-A816-461B-AB87-2FC88D61BEC1Q28731257-077D841B-8ED0-4DDB-81CC-EE56158259BAQ28943412-8436F5B4-B3F2-4913-B3DA-AEC1087B34DCQ28943513-2AB320CB-4796-4E87-BC2D-137DE040A739Q33868026-05DC62A5-0C59-4925-99C2-0834CBA9A18AQ34557794-4B876CC6-937A-4C91-818A-406179FCE67BQ35058477-E262A6E5-C218-4254-BAA3-A3F9D43BB90FQ35556032-A0335687-3505-4958-88E2-C580BEA0D3B7Q36082664-5D2F558E-ECF6-4D62-BCA6-DA14F58A56F9Q36189198-EB1AEF58-C104-45FE-826E-7E066D406EFAQ36952598-A17FB9DA-33F4-472F-900A-C9EB55EB299AQ36972064-E7084EEE-EFF3-47CF-8DFB-17FE150E04E3Q37272338-64F17179-62C6-42D3-A74D-6503D03310D1Q37296048-060EDC5C-D3D8-4A80-BA60-84456D13394CQ37360091-8B921C6B-C058-47FC-9196-C360C3CF2750Q37463998-0EB2471E-9C13-4EC6-9B78-BE12D6F77D8AQ38752201-075CB52A-811D-4F85-AB43-3DE0CB28215BQ40403514-C919FCAD-FF9F-471C-946B-4F47C5CC626BQ44960249-D1EF11A4-CB86-4AE6-9EB5-DC8352F0CEDAQ45658615-C4019247-1965-4B3D-BD68-8624D9558A77Q45915163-80CF91BD-92A6-4C8F-8D2C-1FFDF0616FCBQ46441393-C2D02A1C-94A4-46A2-98B9-8BC7B41F97F0Q46721057-19CE0CFC-5568-48D4-983D-15B78DE573DFQ52291843-38BE18C8-3071-426F-9968-47A8C5E63C0CQ55479814-99B5FDC6-7116-4D35-A62E-9E29200009C9Q60045126-9A5E2C2D-CBF8-42CD-AF21-F732350C0F80Q90576203-A792B272-AAF9-4B05-9B5A-000EC6EF851DQ92623376-AC8035B0-C917-46C5-AA2C-61D2D4869163Q92915637-01971C83-E616-43EC-8A4B-5B3C16B8CDB1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John P Budde
@ast
John P Budde
@en
John P Budde
@es
John P Budde
@nl
type
label
John P Budde
@ast
John P Budde
@en
John P Budde
@es
John P Budde
@nl
altLabel
J P Budde
@en
John Budde
@en
prefLabel
John P Budde
@ast
John P Budde
@en
John P Budde
@es
John P Budde
@nl
P106
P1153
57207802356
P31
P496
0000-0001-7778-7276